Michael Bury | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Michael Bury | Medicine and Dentistry | Best Researcher Award

Academic Teacher at Poznan University of Medical Sciences, Poland

Michał Bury is a dedicated researcher in audiology and neurotology, currently a PhD student at Poznan University of Medical Sciences. With a strong academic foundation, including a master’s degree in Hearing Prosthetics and a bachelor’s in Audiophonology, he has quickly established himself in the field. His research focuses on tinnitus, vestibular disorders, and genetically conditioned auditory defects, contributing to multiple scientific publications in reputable journals such as J. Clin. Med. and Nowa Audiofonologia. He has presented his work at national and international conferences, earning distinctions and certificates for his contributions. As an assistant at multiple universities and a member of the Industry Competence Council under the Ministry of Health, he plays a key role in advancing hearing care. His commitment to interdisciplinary research and public health initiatives underscores his potential as an emerging leader in audiology. With further international collaborations and independent research leadership, his impact is set to grow.

Professional Profile 

Education

Michał Bury has a strong academic background in audiology and medical sciences. He is currently pursuing a PhD at the College of Medical and Health Sciences at Poznan University of Medical Sciences, further advancing his expertise in hearing prosthetics and neurotology. He earned his master’s degree in Hearing Prosthetics (2021-2023) from Poznan University of Medical Sciences, where he specialized in medical sciences with a focus on audiology. Prior to that, he completed a bachelor’s degree in Audiophonology (2018-2021) at Collegium Medicum of Ludwik Rydygier in Bydgoszcz, part of Nicolaus Copernicus University in Torun, with a concentration in health sciences. His academic journey reflects a strong commitment to research and innovation in hearing care. Through his studies, he has developed expertise in audiology, vestibular disorders, and hearing rehabilitation, equipping him with the knowledge and skills to contribute significantly to advancements in auditory health and prosthetics.

Professional Experience

Michał Bury has gained extensive professional experience in audiology, hearing prosthetics, and scientific research. Since October 2023, he has been an assistant at the Department of Hearing Prosthetics and Department of Biophysics at Poznan University of Medical Sciences, where he contributes to research and academic activities. He also holds a position as an assistant at Stanisław Staszic University of Applied Sciences in Piła and will join Adam Mickiewicz University in Poznań as an assistant in 2025. Previously, he worked as a Scientific and Technical Research Specialist at the Department of Biophysics (2022-2023), supporting research on auditory health. Additionally, he has practical experience as an Audiological and Otoneurological Diagnostician at MedSłuch Laboratory of Hearing and Balance Tests. His diverse roles highlight his expertise in both clinical and academic settings, demonstrating his dedication to advancing research and education in hearing science, audiology, and neurotology.

Research Interest

Michał Bury’s research interests focus on audiology, neurotology, and hearing care, with a particular emphasis on the diagnosis and rehabilitation of auditory disorders. His work explores the role of the vestibular and auditory systems in aging populations, tinnitus, and genetically conditioned hearing defects. He is also interested in hearing prosthetics and their application in rare diseases, as well as the co-occurrence of temporomandibular disorders in patients with tinnitus. His studies integrate medical sciences, health sciences, and biophysics to improve hearing diagnostics and rehabilitation strategies. Through his research, he aims to enhance clinical approaches to audiological and otoneurological conditions, contributing to advancements in patient care. His commitment to interdisciplinary collaboration and innovation in hearing prosthetics underscores his role in shaping the future of auditory health. By combining academic research with practical applications, he seeks to develop more effective treatments and interventions for individuals with hearing impairments.

Award and Honor

Michał Bury has received several awards and honors in recognition of his contributions to audiology and hearing research. He was awarded a certificate for presenting his paper, The Role of Vestibular and Auditory System Examination in the Elderly, at the Polish Society of Otolaryngologists, Head and Neck Surgeons Congress (UCHO 2024) in Warsaw. He also received a certificate for his presentation on Diagnosis and Rehabilitation of the Auditory System in Genetically Conditioned Defects at the 17th Scientific and Training Conference of the Audiology and Phoniatrics Section in Łódź. Additionally, he was honored with a certificate from the Minister of Health of Ukraine and the Rector of Bukovinian State Medical University for his research on otosclerosis. His academic achievements have also been recognized with a distinction from the Rector of Poznan University of Medical Sciences in a diploma thesis competition. These accolades highlight his growing impact in auditory sciences and medical research.

Research Skill

Michał Bury possesses strong research skills in audiology, neurotology, and hearing prosthetics, with expertise in both experimental and clinical studies. He is proficient in conducting systematic reviews and meta-analyses, as demonstrated in his publication on the co-occurrence of temporomandibular disorders and tinnitus. His ability to design and execute research studies is evident in his work on vestibular and auditory system examinations in elderly patients and genetically conditioned hearing defects. He is skilled in audiological diagnostics, data analysis, and interdisciplinary research, integrating medical sciences, biophysics, and health sciences. His experience in presenting research at national and international conferences reflects his ability to communicate complex findings effectively. Additionally, his involvement in hearing loss awareness programs and professional organizations demonstrates his capacity for applied research and innovation. With a growing publication record and a commitment to advancing auditory health, he continues to refine his research methodology and scientific contributions.

Conclusion

Michał Bury is a highly promising researcher with strong academic, scientific, and professional credentials in audiology and hearing prosthetics. His multiple publications, conference presentations, and industry memberships highlight his dedication to advancing the field. While he is still in the early stages of his PhD journey, his rapid progress and contributions already set him apart.

If the Best Researcher Award prioritizes early-career excellence, research output, and impact in audiology, he is a strong candidate. However, securing more leadership roles, international collaborations, and funding could further enhance his chances in future prestigious research awards.

Publications Top Noted

  • Bury, M., Nijakowski, K., Majewska, A., Jankowski, J., Surdacka, A., & Hojan-Jezierska, D. (2025). The Co-Occurrence of Temporomandibular Disorders in Patients Diagnosed with Tinnitus: A Systematic Review with Meta-Analysis. Journal of Clinical Medicine, 14(6), 1836. DOI: 10.3390/jcm14061836.

  • Bury, M., Frąszczak, P., & Kędziora-Kornatowska, K. (2020). The Functioning of the Patient in the Mental Aspect and Interpersonal Relationships After Laryngectomy Surgery. Journal of Education, Health and Sport, 10(9), 473-480. DOI: 10.12775/JEHS.2020.10.09.056.

Liying Zhang | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liying Zhang | Medicine and Dentistry | Best Researcher Award

Professor at University of California, Los Angeles, United States

Dr. Liying Zhang, MD, PhD, FACMG, is a distinguished researcher and professor specializing in molecular diagnostics and precision oncology. She serves as the Director of the Advanced Molecular Diagnostics Service at UCLA David Geffen School of Medicine and the Director of Cancer Molecular Diagnostics at UCLA Jonsson Comprehensive Cancer Center. With extensive experience in molecular genetics, her research focuses on cancer diagnostics, biomarker discovery, and precision medicine. She has contributed to numerous high-impact studies, secured significant research funding, and played an active role in national and international expert committees. Her expertise spans clinical molecular genetics, genomics, bioinformatics, and laboratory medicine, making her a leading figure in the field of cancer molecular diagnostics.

Professional Profile 

Education

Dr. Zhang earned her Ph.D. in Biochemistry and Molecular Biology from The Johns Hopkins University in 2003, alongside a Master’s degree in Computer Science with a focus on Bioinformatics in 2002. She obtained her MD from Peking University, Beijing, China, in 1994. She holds multiple clinical licensures and board certifications, including Clinical Molecular Genetics and Genomics from the American Board of Medical Genetics and Genomics. Her strong educational foundation in medicine, biochemistry, molecular biology, and computational science has equipped her with the interdisciplinary expertise required for advancing molecular diagnostics and precision medicine.

Professional Experience

Dr. Zhang has held several prestigious roles in molecular pathology and diagnostics. Since 2020, she has been a Professor and Director at UCLA, leading advanced molecular diagnostics initiatives. Previously, she served as a Director and Molecular Geneticist at Memorial Sloan Kettering Cancer Center from 2005 to 2019, overseeing diagnostic molecular genetics laboratories and contributing to groundbreaking cancer research. Her earlier roles include research positions at the National Research Institute for Family Planning in China. Additionally, she has been actively involved in professional committees, journal reviews, and mentorship programs, furthering advancements in molecular diagnostics and genetic research.

Research Interest

Dr. Liying Zhang’s research focuses on molecular diagnostics, cancer genomics, and precision oncology. She is dedicated to identifying genetic biomarkers that enhance cancer detection, prognosis, and treatment strategies. Her work involves integrating next-generation sequencing (NGS) technologies, bioinformatics, and molecular pathology to improve the accuracy and efficiency of cancer diagnostics. She is particularly interested in the molecular mechanisms underlying tumor development, drug resistance, and targeted therapies. Through collaborations with oncologists, geneticists, and data scientists, she aims to translate genetic findings into clinically actionable insights that improve patient outcomes. Her research also extends to liquid biopsy, epigenetics, and the development of novel molecular assays for early cancer detection.

Awards and Honors

Dr. Zhang has received numerous prestigious awards recognizing her contributions to molecular genetics and cancer diagnostics. She has been honored as a Fellow of the American College of Medical Genetics and Genomics (FACMG), acknowledging her leadership and expertise in clinical molecular genetics. She has also received research excellence awards from institutions such as Memorial Sloan Kettering Cancer Center and UCLA for her groundbreaking work in cancer molecular diagnostics. Additionally, she has been an invited speaker at leading international conferences, including the American Society of Human Genetics (ASHG) and the Association for Molecular Pathology (AMP). Her contributions to scientific research and clinical practice have earned her recognition as a thought leader in precision medicine and molecular oncology.

Research Skills

Dr. Zhang possesses a diverse range of research skills in molecular diagnostics and genomics. She is proficient in next-generation sequencing (NGS) technologies, whole-genome and transcriptome analysis, and single-cell sequencing. She has extensive experience in bioinformatics, data mining, and computational modeling for genetic variant interpretation. Her expertise includes designing and validating molecular assays for clinical diagnostics, including PCR-based and hybrid capture-based sequencing methods. She is also skilled in laboratory management, regulatory compliance, and quality control in clinical molecular genetics laboratories. Additionally, her strong background in translational research allows her to bridge the gap between basic scientific discoveries and clinical applications, ensuring that her findings have a direct impact on patient care and personalized treatment strategies.

Conclusion

Dr. Liying Zhang is highly suitable for the Best Researcher Award due to her exceptional contributions to molecular diagnostics, cancer genomics, and precision medicine. Her extensive experience in research leadership, grant acquisition, and clinical applications makes her an outstanding candidate. Strengthening her independent research leadership and international collaborations would further solidify her candidacy for this prestigious award.

Publications Top Noted

  • Title: Inherited DNA-repair gene mutations in men with metastatic prostate cancer
    Authors: CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, …
    Year: 2016
    Citation: 1765

  • Title: Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    Authors: L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw
    Year: 2010
    Citation: 1402

  • Title: Long-term follow-up of a large active surveillance cohort of patients with prostate cancer
    Authors: L Klotz, D Vesprini, P Sethukavalan, V Jethava, L Zhang, S Jain, …
    Year: 2015
    Citation: 1399

  • Title: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct
    Authors: IYL Tan, AM Demchuk, J Hopyan, L Zhang, D Gladstone, K Wong, …
    Year: 2009
    Citation: 792

  • Title: Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
    Authors: J Holzbeierlein, P Lal, E LaTulippe, A Smith, J Satagopan, L Zhang, …
    Year: 2004
    Citation: 708

  • Title: Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Authors: A Latham, P Srinivasan, Y Kemel, J Shia, C Bandlamudi, D Mandelker, …
    Year: 2019
    Citation: 591

  • Title: Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
    Authors: W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, …
    Year: 2017
    Citation: 583

  • Title: Celiac disease: summary
    Authors: A Rostom, C Dubé, A Cranney, N Saloojee, R Sy, C Garritty, M Sampson, …
    Year: 2004
    Citation: 511

  • Title: Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Authors: D Mandelker, L Zhang, Y Kemel, ZK Stadler, V Joseph, A Zehir, …
    Year: 2017
    Citation: 508

  • Title: Tumour lineage shapes BRCA-mediated phenotypes
    Authors: P Jonsson, C Bandlamudi, ML Cheng, P Srinivasan, SS Chavan, …
    Year: 2019
    Citation: 384

  • Title: Hereditary diffuse gastric cancer: updated clinical practice guidelines
    Authors: VR Blair, M McLeod, F Carneiro, DG Coit, JL D’Addario, JM van Dieren, …
    Year: 2020
    Citation: 381

  • Title: Update of the international consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases
    Authors: E Chow, P Hoskin, G Mitera, L Zeng, S Lutz, D Roos, C Hahn, …
    Year: 2012
    Citation: 374

  • Title: Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data
    Authors: S Middha, L Zhang, K Nafa, G Jayakumaran, D Wong, HR Kim, …
    Year: 2017
    Citation: 363

  • Title: Genetic predictors of response to systemic therapy in esophagogastric cancer
    Authors: YY Janjigian, F Sanchez-Vega, P Jonsson, WK Chatila, JF Hechtman, …
    Year: 2018
    Citation: 352

Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Liat Waldman Radinsky | Medicine and Dentistry | Best Researcher Award

Sheba Medical Center, Israel

Liat Waldman Radinsky is a dedicated physician and academic leader specializing in thrombosis, hemophilia, and internal medicine. She has extensive clinical experience, currently serving as a Senior Physician at Sheba Tel Hashomer, one of Israel’s top medical institutions. Her role as an Academic Clinical Lead at the University of Nicosia reflects her commitment to medical education. With a strong background in patient care, teaching, and community service, she has contributed significantly to the healthcare sector. Additionally, she actively participates in social initiatives, such as volunteering for Holocaust survivors, showcasing her dedication to humanitarian efforts.

Professional Profile 

Education

Liat Waldman Radinsky earned her M.D. from Ben-Gurion University of the Negev (2012-2015), following a B.Sc. in Medical Sciences from the same institution (2009-2012). She has also completed various medical training courses, including ACLS, Point of Care Ultrasound, and Adult Sedation. Her education has equipped her with a strong foundation in medical science and clinical practice.

Professional Experience

Liat has held multiple roles in prestigious medical institutions. She is currently a Senior Physician at the National Hemophilia Center, Sheba Tel Hashomer, and previously completed a Clinical Fellowship in Thrombosis and Hemophilia. Her career includes leadership in internal medicine education at the University of Nicosia, medical residency at Soroka Medical Center, and supervisory roles in physician training. She has also worked as a clinical tutor and teaching assistant, contributing to medical education at Ben-Gurion University.

Research Interest

Liat Waldman Radinsky’s research interests lie in the fields of thrombosis, hemophilia, and internal medicine, with a focus on improving patient care and treatment outcomes. Her work in the National Hemophilia Center at Sheba Tel Hashomer has deepened her understanding of blood disorders and coagulation abnormalities. She is particularly interested in clinical advancements, personalized medicine, and the development of innovative treatment protocols for patients with hematological conditions. Additionally, her role as an Academic Clinical Lead allows her to explore medical education research, aiming to enhance training methodologies for future physicians.

Awards and Honors

Throughout her medical career, Liat Waldman Radinsky has been recognized for her excellence in clinical practice and education. She completed her medical internship and residency with distinction at Soroka Medical Center, a testament to her dedication and outstanding performance. Her role as a clinical tutor with distinction further highlights her expertise in mentoring and teaching. Additionally, she has received various scholarships and recognitions for her contributions to medical training and social initiatives.

Research Skills

Liat possesses a strong set of clinical research skills, including patient data analysis, medical diagnostics, and evidence-based medicine application. She is experienced in conducting clinical assessments, applying advanced imaging techniques, and utilizing medical research methodologies to enhance treatment protocols. Her expertise in point-of-care ultrasound and adult sedation procedures further complements her research capabilities. Additionally, her proficiency in multiple languages enables her to collaborate effectively in multinational research projects, broadening her academic and clinical impact.

Conclusion

Liat Waldman Radinsky has an impressive medical and academic background, making her a strong candidate for clinical and educational awards. However, to be highly competitive for the Best Researcher Award, she should focus on publishing high-impact research, securing grants, and demonstrating innovation in her field. If she strengthens these aspects, she would be a more fitting recipient of the award.

Publications Top Noted

Title: Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

Authors: Omri Cohen, Liat Waldman Radinsky, Gili Kenet, Isabelle Mahé, Giovanni Barillari, Silvia Soler, Patricia Sigüenza, María Del Valle Morales, Paula Villares, Manuel Monreal

Year: 2024

Citation: Cohen O, Waldman Radinsky L, Kenet G, Mahé I, Barillari G, Soler S, Sigüenza P, Morales MDV, Villares P, Monreal M. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia. Blood Advances. 2024; DOI: 10.1182/bloodadvances.2024012611.

Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mrs. Wenxiu Tian | Medicine and Dentistry | Best Researcher Award

Supervising Medical Laboratory Technologist at Zibo Central Hospital, China

Mrs. Wenxiu Tian is an accomplished Supervising Medical Laboratory Technologist at the Center of Translational Medicine, Zibo Central Hospital, with a strong academic and research background in oncology and molecular biology. Holding a Master’s degree from Shandong Second Medical University, she has demonstrated her expertise through the publication of 9 SCI-indexed papers, including multiple first-author and corresponding-author contributions. Her research focuses on the molecular mechanisms of melanoma, nasopharyngeal carcinoma, and pancreatic cancer, with particular emphasis on ferroptosis and lipid metabolism, contributing to advancements in cancer therapeutics. Mrs. Tian has also led a Shandong Provincial Medical and Health project and received the Youth Talent Award from Zibo Central Hospital in recognition of her contributions. With collaborative publications, successful project funding, and an ongoing patent application, Mrs. Tian continues to play a key role in translational cancer research, combining innovative approaches with strong scientific rigor to improve cancer diagnostics and treatment.

Professional Profile 

Education

Mrs. Wenxiu Tian holds a Master’s degree in Biochemistry and Molecular Biology from Shandong Second Medical University, earned between 2019 and 2022. During her postgraduate studies, she focused extensively on molecular oncology, particularly exploring mechanisms related to cancer pathogenesis and potential therapeutic targets. Her academic training equipped her with advanced laboratory techniques, data analysis skills, and a deep understanding of cellular and molecular processes underlying cancer development. During her Master’s program, Mrs. Tian actively engaged in research, resulting in the publication of 4 SCI papers, including 2 as first author, demonstrating her ability to lead and contribute to high-impact scientific work. Her academic foundation combines strong theoretical knowledge with practical research expertise, preparing her for a successful career in translational medicine. This solid educational background has enabled her to excel in her current role at Zibo Central Hospital, where she continues to integrate academic research with clinical applications.

Professional Experience

Mrs. Wenxiu Tian has accumulated over 10 years of professional experience in the field of medical laboratory technology and translational medicine, with a focus on oncology research. She began her career in 2015 at Zibo Central Hospital, where she currently serves as a Supervising Medical Laboratory Technologist in the Center of Translational Medicine. In this role, she leads molecular biology research projects, conducts advanced laboratory diagnostics, and collaborates with clinical teams to apply research findings to patient care. Throughout her career, Mrs. Tian has demonstrated strong expertise in cancer biomarker discovery, ferroptosis mechanisms, and lipid metabolism in tumors, contributing to improved understanding of melanoma, nasopharyngeal carcinoma, and pancreatic cancer. Her work has resulted in multiple SCI publications, a provincial research project, and a patent under development. Mrs. Tian’s blend of technical laboratory skills, research leadership, and commitment to advancing cancer diagnostics and treatment makes her a valuable asset to the medical and scientific community.

Research Interest

Mrs. Wenxiu Tian’s research interests lie primarily in the field of oncology, with a particular focus on understanding the molecular mechanisms driving cancer progression and treatment resistance. Her work centers on exploring ferroptosis, a newly recognized form of programmed cell death, and its role in cancers such as melanoma, nasopharyngeal carcinoma, and pancreatic cancer. She is especially interested in the interplay between lipid metabolism and tumor microenvironments, aiming to identify novel molecular biomarkers and therapeutic targets for early diagnosis and personalized cancer treatment. Mrs. Tian also investigates the role of tumor suppressor genes, oncogenes, and signaling pathways in regulating cancer cell survival, proliferation, and metastasis. Her research integrates basic molecular biology techniques with translational applications, bridging the gap between benchside discoveries and bedside care. With an emphasis on collaborative, multi-disciplinary research, she aims to contribute to the development of more effective, targeted therapies to improve cancer outcomes.

Award and Honor

Mrs. Wenxiu Tian has received recognition and honors for her outstanding contributions to cancer research and translational medicine. One of her most notable achievements is being awarded the prestigious “Youth Talent” title by Zibo Central Hospital, acknowledging her exceptional work in molecular oncology research and her leadership in advancing innovative approaches to cancer diagnosis and treatment. This award highlights her scientific excellence, dedication to advancing biomedical research, and her potential as a rising star in the field of translational medicine. In addition to institutional recognition, Mrs. Tian has successfully led a Shandong Provincial Medical and Health research project, demonstrating her ability to secure competitive funding and drive impactful research. Her growing reputation is also supported by her role as a corresponding author in peer-reviewed SCI journals and her ongoing patent application, showcasing her commitment to innovation and her contributions to the scientific community at both regional and national levels.

Research skill

Mrs. Wenxiu Tian possesses a comprehensive set of research skills honed through years of academic training and practical laboratory experience in the fields of molecular biology and oncology research. Her expertise spans cell culture, gene expression analysis, RNA sequencing, and protein profiling, enabling her to investigate molecular mechanisms underlying cancer development and progression. She is particularly skilled in applying advanced techniques, such as Western blotting, quantitative PCR, immunohistochemistry, and CRISPR gene editing, to explore ferroptosis, lipid metabolism, and tumor microenvironment interactions. Mrs. Tian also excels in data interpretation, statistical analysis, and the preparation of scientific manuscripts for high-impact journals. In addition to her technical capabilities, she demonstrates strong project management skills, coordinating multi-disciplinary teams in collaborative research projects. Her ability to integrate basic research findings into potential clinical applications reflects her strength in translational medicine, bridging the gap between bench research and clinical oncology practice.

Conclusion

Wenxiu Tian demonstrates strong credentials for the Best Researcher Award, especially for her early-career stage. Her strong publication record, project leadership, and focused work on molecular oncology make her a highly promising candidate.

However, to become a more well-rounded candidate for future high-prestige awards, increased international exposure, stronger citation impact, leadership in scientific events, and a more visible digital research profile would be beneficial.

Publications Top Noted

  • “A Bibliometric Analysis of 3D Printing in Personalized Medicine Research from 2012 to 2022”

    • Year: 2022
    • Citations: Not specified in the provided data.
    • DOI: Not provided.
    • Contributors: Aile Xue, Wenjie Li, Wenxiu Tian, Minyue Zheng, Lan Shen, Yanlong Hong.
    • Source: ResearchGate

  • “A novel nonsense variant in PLS3 causes X-linked osteoporosis in a Chinese family”

    • Year: 2019
    • Citations: Not specified in the provided data.
    • DOI: 10.1111/ahg.12344
    • Contributors: Not specified in the provided data.
    • Source: ORCID

  • “Application of Doppler effect and design of Doppler effect demonstration device”

    • Year: 2024
    • Citations: Not specified in the provided data.
    • DOI: 10.1117/12.3026485
    • Contributors: Not specified in the provided data.
    • Source: SPIE Digital Library

  • “Designing and deploying a mixed-reality aquarium for children with autism spectrum disorder”

    • Year: 2020
    • Citations: Not specified in the provided data.
    • DOI: 10.1007/s11432-020-2941-7
    • Contributors: Not specified in the provided data.
    • Source: Springer

  • “Controllable formation of meso- and macropores within metal–organic frameworks mediated by citric acid”

    • Year: 2018
    • Citations: Not specified in the provided data.
    • DOI: 10.1039/C8NR02896F
    • Contributors: Not specified in the provided data.
    • Source

Mike Sabeti | Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Mike Sabeti | Dentistry | Best Researcher Award

PG director at UCSF, United States

Professor Mike A. Sabeti, DDS, MA, is a distinguished clinician, researcher, and educator specializing in endodontics and periodontology. Currently serving as a Clinical Professor and Director of Post-Graduate Endodontics at UCSF, he has made significant contributions to dental education and research. With extensive experience in virology, microbiology, regeneration, and bone resorption, he has actively shaped the field through numerous editorial roles, peer-reviewed publications, and research collaborations. His dedication to academic excellence has earned him multiple awards, including the Journal of Endodontics Award (2022) and UCSF’s Excellence in Teaching Award (2019). A recognized leader, he has served as President of the Northern California Academy of Endodontics and contributed to updating vital pulp therapy guidelines. As an invited speaker at global conferences, he continues to influence the future of endodontics. His unwavering commitment to research, teaching, and clinical excellence makes him a key figure in the advancement of dental science.

Professional Profile 

Education

Professor Mike A. Sabeti, DDS, MA, has an extensive and diverse educational background in dentistry and related fields. He earned his Doctor of Dental Surgery (DDS) from the University of Texas Health Science Center at Houston (1993), laying the foundation for his career in dentistry. He further specialized by completing Advanced Education in Periodontology at Tufts School of Dental Medicine (1993-1995) and later pursued Advanced Education in Endodontics at the University of Southern California (2000-2002). In addition to his dental expertise, he holds a Master’s degree in English Literature from Prairie View A&M University (1987-1989), showcasing his broad academic interests. His commitment to excellence is reflected in his multiple professional certifications, including being board-certified by the American Board of Endodontics (2008) and holding dental licenses in both California and Texas. His strong academic foundation has paved the way for his successful career as a clinician, educator, and researcher in the field of endodontics.

Professional Experience

Professor Mike A. Sabeti, DDS, MA, has an extensive professional career spanning over three decades in endodontics, periodontology, research, and education. Currently, he serves as a Clinical Professor and Director of Post-Graduate Endodontics at UCSF, where he oversees resident training and clinical research. Previously, he held academic positions at Loma Linda University, the University of Southern California (USC), and the University of Texas at Houston, contributing significantly to dental education. He has also served as a visiting researcher in endodontics, oral maxillofacial surgery, and orthodontics at USC. Beyond academia, Dr. Sabeti has been actively involved in professional organizations, including serving as President of the Northern California Academy of Endodontics and a site visitor for the American Dental Association. With numerous international speaking engagements, editorial board memberships, and contributions to endodontic research and education, he remains a highly respected leader in the advancement of dental sciences.

Research Interest

Professor Mike A. Sabeti, DDS, MA, has a diverse and impactful research portfolio focused on advancing dental science, particularly in endodontics, periodontology, and regenerative medicine. His primary research interests include virology, microbiology, bone resorption, regeneration, and dental implants, with an emphasis on improving clinical outcomes in endodontic and periodontal treatments. As a highly active researcher and editorial board member, he has contributed to numerous peer-reviewed publications and serves as a reviewer for esteemed journals like the Journal of Endodontics and the International Endodontic Journal. His work in vital pulp therapy, bioceramics, and the perio-endo interrelationship has significantly influenced clinical practices. Additionally, he has been involved in guideline development for the American Association of Endodontics and the American Academy of Pediatric Dentistry. Through his ongoing research, international lectures, and collaborations, Dr. Sabeti continues to shape the future of endodontic science and patient care.

Award and Honor

Professor Mike A. Sabeti, DDS, MA, has received numerous prestigious awards and honors in recognition of his excellence in research, education, and clinical practice. In 2022, he was awarded the Journal of Endodontics Award by the American Association of Endodontists, highlighting his significant contributions to endodontic research. His dedication to teaching earned him UCSF’s Excellence in Teaching Award (2019) and the Faculty of the Year Award (2018) at the Community Dental Clinic. He has also been recognized for his outstanding service at the Herman Ostrow School of Dentistry at USC, receiving multiple certificates of appreciation for over a decade of contributions. Additionally, he has been named among “Best Doctors in America” (2009) and “American Top Dentists” (2003, 2006). His accolades reflect his leadership, innovation, and commitment to advancing dental education, endodontic research, and patient care on both national and international levels.

Research Skill

Professor Mike A. Sabeti, DDS, MA, possesses exceptional research skills that have contributed significantly to the fields of endodontics, periodontology, and regenerative dentistry. His expertise spans virology, microbiology, bone resorption, and biomaterials, with a strong focus on dental regeneration and implantology. As an editorial board member and peer reviewer for numerous prestigious journals, he demonstrates a keen analytical ability, critical thinking, and in-depth knowledge of current scientific advancements. His contributions include clinical trials, systematic reviews, and guideline development for organizations like the American Association of Endodontics and the American Academy of Pediatric Dentistry. Additionally, his ability to collaborate internationally, mentor postgraduate researchers, and present findings at global conferences showcases his dedication to advancing dental research. His meticulous approach to study design, data analysis, and evidence-based practice ensures that his research has a meaningful impact on clinical dentistry and patient outcomes worldwide.

Conclusion

Dr. Mike A. Sabeti is a highly accomplished academic, clinician, and researcher with a strong record of teaching, clinical supervision, and editorial contributions to the field of Endodontics. His multiple awards, leadership roles, and invited speaker engagements make him an excellent candidate for the Best Researcher Award.

To further strengthen his case, more independent primary research publications and research funding acquisitions would enhance his recognition as a leading researcher. However, based on his overall contributions to dental research, education, and professional organizations, he is undoubtedly a strong and deserving candidate for this award.

Publications Top Noted

Title: Polysaccharide-based (kappa carrageenan/carboxymethyl chitosan) nanofibrous membrane loaded with antifibrinolytic drug for rapid hemostasis – in vitro and in vivo evaluation

Authors: S.S. Salmasi, Sara Salamzadeh, M. Ehsani, Morteza, M. Zandi, Mojgan, M. Saeed, Mahdi, M. Sabeti, Mike

Journal: International Journal of Biological Macromolecules

Year: 2023

Citations: 6

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490

 

 

Nada Bochor | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Nada Bochor | Medicine and Dentistry | Best Researcher Award

Doctor at Perth Children’s Hospital, United Arab Emirates

Dr. Nada Bochor is a dedicated medical professional with three years of diverse experience in clinical practice, research, and leadership. She has worked across multiple specialties, including emergency medicine, surgery, respiratory medicine, and general practice, demonstrating strong diagnostic, procedural, and patient management skills. Dr. Bochor has contributed significantly to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies, along with publications in esteemed journals like MDPI and the Irish Journal of Medical Science. Her leadership roles in hospital committees, volunteer initiatives, and medical education highlight her commitment to improving healthcare outcomes. She has also undertaken international clinical electives, enhancing her expertise in point-of-care ultrasonography, infectious diseases, and humanistic healthcare. Driven by innovation and evidence-based practice, Dr. Bochor’s passion for advancing medical research and patient care makes her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Dr. Nada Bochor has a strong academic background in medicine, complemented by extensive clinical training and research experience. She earned her medical degree from a prestigious institution, where she excelled in both theoretical and practical aspects of healthcare. Throughout her education, she pursued diverse clinical rotations in emergency medicine, surgery, respiratory medicine, and general practice, gaining hands-on experience in patient care, diagnostics, and treatment. Dr. Bochor has actively engaged in medical research, presenting her findings at esteemed conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. She has also contributed to reputable journals, including MDPI and the Irish Journal of Medical Science. Additionally, she has undertaken specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare during international clinical electives. Her dedication to continuous learning and evidence-based medicine highlights her commitment to advancing medical knowledge and improving patient outcomes.

Professional Experience

Dr. Nada Bochor has extensive professional experience in clinical medicine, research, and medical education. She has worked across various medical specialties, including emergency medicine, general practice, surgery, and respiratory medicine, providing comprehensive patient care and honing her diagnostic and procedural skills. She has actively contributed to medical research, with presentations at prestigious conferences such as the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work has been published in renowned journals like MDPI and the Irish Journal of Medical Science, reflecting her commitment to evidence-based medicine. Dr. Bochor has also pursued specialized training in point-of-care ultrasonography, infectious diseases, and humanistic healthcare, enhancing her expertise in patient-centered care. Her international clinical electives have broadened her perspective on global healthcare challenges. With a passion for continuous learning and medical innovation, she remains dedicated to advancing healthcare through research, clinical excellence, and medical education.

Research Interest

Dr. Nada Bochor’s research interests lie at the intersection of clinical medicine, respiratory health, infectious diseases, and medical education. She is particularly passionate about advancing diagnostic and treatment strategies for respiratory conditions, as evidenced by her contributions to the Irish Thoracic Society and the European Academy of Paediatric Societies. Her work explores the impact of infectious diseases on global health, emphasizing early detection and effective management. Additionally, she is keen on integrating point-of-care ultrasonography into routine clinical practice to enhance real-time diagnostics. Dr. Bochor is also dedicated to improving medical education by developing innovative training programs that emphasize humanistic healthcare and patient-centered approaches. She actively engages in interdisciplinary research, seeking to bridge the gap between clinical practice and academic medicine. Through her work, she aims to contribute to the evolution of healthcare policies and medical practices, ensuring improved patient outcomes and advancing global healthcare standards.

Award and Honor

Dr. Nada Bochor has received numerous awards and honors in recognition of her outstanding contributions to clinical medicine, research, and medical education. She has been honored by the Irish Thoracic Society for her significant work in respiratory health and has received accolades from the European Academy of Paediatric Societies for her research on infectious diseases. Her excellence in medical education and dedication to training future healthcare professionals have also earned her prestigious teaching awards. Dr. Bochor has been recognized for her leadership in integrating point-of-care ultrasonography into clinical practice, receiving commendations from both national and international medical organizations. Her contributions to global health initiatives and patient-centered care have led to invitations as a keynote speaker at leading medical conferences. Through her groundbreaking research, innovative clinical approaches, and commitment to medical education, Dr. Bochor continues to be celebrated as a leader in her field, inspiring the next generation of healthcare professionals.

Research Skill

Dr. Nada Bochor possesses a diverse and advanced set of research skills that have significantly contributed to the fields of clinical medicine and medical education. Her expertise includes designing and conducting clinical trials, systematic reviews, and meta-analyses to evaluate the effectiveness of novel diagnostic and treatment approaches. She is proficient in statistical analysis, utilizing advanced biostatistical methods and software to interpret complex medical data. Dr. Bochor has a strong background in qualitative and quantitative research methodologies, allowing her to explore patient-centered care models and healthcare system improvements. She is skilled in grant writing and securing research funding, enabling her to lead multidisciplinary projects that bridge clinical practice and medical innovation. Additionally, her ability to synthesize scientific literature and produce high-impact publications has earned her recognition in international medical journals. Through her rigorous research skills, Dr. Bochor continues to advance medical knowledge, influence clinical guidelines, and enhance patient outcomes worldwide.

Conclusion

Nada Bochor is a strong candidate for the Best Researcher Award, given her clinical research contributions, conference presentations, and publications. However, increasing the volume of high-impact research and demonstrating direct innovation in healthcare could further strengthen her application.

Publications Top Noted

  • Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives
    Authors: Nada Bochor, Gera Parshotam
    Year: 2024 (Preprint)
    Citation: Bochor, N., & Parshotam, G. (2024). Exploring Lymphangioma: A Synthesis of Literature and Clinical Perspectives. [Preprint].

  • An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy
    Authors: Joseph McHugh, Nada Bochor, C. Conta[…], B. Casserly
    Year: 2022 (Poster)
    Citation: McHugh, J., Bochor, N., Conta, C., & Casserly, B. (2022). An Unusual Case of Respiratory Failure in a Patient on Rituximab Therapy. [Poster].